Reprogramming Mitochondrial Adaptation: LONP1 at the Crossroads of Proteostasis, Metabolism, and Disease
Antioxidants · 25.06.2026 · 15 (7) · 793
DOI: 10.3390/antiox15070793 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 25.06.2026. Verfasst von Hsu-Hung Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Sijhih Cathay General Hospital, New Taipei City 221, Taiwan. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cathay General Hospital, Cathay General Hospital in Taipei.
Abstract (Originalsprache)
Mitochondrial Lon peptidase 1 (LONP1) is an ATP-dependent AAA+ (ATPases associated with diverse cellular activities) protease that has emerged as a key regulator of mitochondrial proteostasis, with functions extending beyond protein quality control. In addition to degrading misfolded and oxidized proteins, LONP1 coordinates mitochondrial DNA maintenance, metabolic remodeling, and stress-responsive signaling. Recent structural and functional advances have expanded the biological significance of LONP1 beyond protein quality control, highlighting its roles in mitochondrial metabolism, genome maintenance, and stress responses. LONP1 dysregulation is increasingly implicated in cancer, metabolic disorders, neurodegeneration, and aging, where it exerts context-dependent effects on cell survival and disease progression. In cancer, LONP1 supports metabolic plasticity, redox adaptation, and therapeutic resistance, whereas in degenerative conditions, its decline contributes to mitochondrial dysfunction and tissue damage. Here, we synthesize recent insights into the structure, mechanisms, and biological functions of LONP1 and discuss their implications for human disease. We further discuss emerging therapeutic strategies and key challenges for targeting LONP1 in human disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Sijhih Cathay General Hospital, New Taipei City 221, Taiwan.
- School of Biological Sciences, University of California, San Diego, CA 92093, USA.
- Department of Research, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.
- Institute of Oral Medicine and Materials, College of Medicine, Tzu Chi University, Hualien 970, Taiwan.
ORCID-Profile: Chung-Che Tsai, Chan-Yen Kuo
Förderung
- Cathay General Hospital
- Cathay General Hospital in Taipei
Zitieren
APA
Chang, H. H., Chang, P. T. S., Tsai, C. C., & Kuo, C. Y. (2026). Reprogramming Mitochondrial Adaptation: LONP1 at the Crossroads of Proteostasis, Metabolism, and Disease. Antioxidants, 15(7), 793. https://doi.org/10.3390/antiox15070793
Vancouver
Chang HH, Chang PTS, Tsai CC, Kuo CY. Reprogramming Mitochondrial Adaptation: LONP1 at the Crossroads of Proteostasis, Metabolism, and Disease. Antioxidants. 2026;15(7):793. doi:10.3390/antiox15070793
BibTeX
@article{Chang2026,
author = {Chang, Hsu-Hung and Chang, Phebe Ting Syuan and Tsai, Chung-Che and Kuo, Chan-Yen},
title = {Reprogramming Mitochondrial Adaptation: LONP1 at the Crossroads of Proteostasis, Metabolism, and Disease},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {7},
pages = {793},
doi = {10.3390/antiox15070793}
}
EUVIMED